A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
This protocol will explain how to establish a hypertrophic scarring murine model that increases mechanotransduction signaling to simulate human-like scarring. This method involves increasing mechanical tension across a healing incision in a mouse and using a specialized device to create reproducible, excessive scar tissue for detailed histological and bioinformatic analyses.
Hypertrophic scarring (HTS) is an abnormal process of wound healing that results in excessive scar tissue formation. Over the past decade, we have demonstrated that mechanotransduction—the conversion of mechanical stimuli into cellular responses—drives excessive fibrotic scar healing. A mouse model to assess human-like hypertrophic scarring would be an essential tool for examining various therapeutics and their ability to reduce scarring and improve healing. Specifically, our laboratory has developed a murine wound model that increases mechanical strain to promote human-like HTS. This protocol utilizes biomechanical loading devices, made from modified 13 mm palatal expanders, whose arms are placed on either side of the incision and distracted incrementally apart in order to apply continuous tension across the wound bed during healing. Over nearly two decades of use, this model has been significantly advanced to improve efficacy and reproducibility. Using the murine HTS model, significant dermal fibrotic scars can be induced to be histologically comparable to human hypertrophic scars. This murine model provides an environment to develop biologics involved in the treatment of HTS and mechanotransduction-related conditions such as foreign body response.
Wound healing, the process by which the body attempts to repair damaged tissue and rebuild the skin barrier, can result in atypical healing if its processes of hemostasis, inflammation, proliferation, and remodeling are irregular1. Hypertrophic scarring (HTS) is an example of irregular wound healing, characterized by excessive deposition of extracellular matrix and connective tissue at the site of injury resulting in the formation of an enlarged scar tissue area1,2,3. Areas on the body that undergo repeated mechanical stretch stimulations, such as arou....
Approval from the University of Arizona Institutional Animal Care and Use Committee (IACUC) was obtained for all experiments (control number: 2021-0828). This protocol uses 15-week-old C57BL/6J male mice although it could be applied to other ages and strains9,26.
1. Creating the HTS biomechanical loading device
NOTE: Modifying the palatal expanders into the HTS device can occur at any point be.......
To clearly demonstrate the effective use of the HTS protocol and identify successful "positive" results, the model was established as shown in Figure 3A. In the representative study, there were two groups: No Stretch Control (n = 6) and Mechanical Stretch HTS group (n = 6) where human-like levels of mechanical strain were induced across the incision to generate an HTS, seen in Figure 3B,C. Within the experimental plan given in
The HTS mouse model is a cost-effective and highly reproducible method for inducing HTS via mechanotransduction and developing potential therapies. While there is an initial learning curve to effectively use the model, the protocol can, with practice, be performed by any researcher without surgical training. Using this model allows researchers to better understand HTS formation and the role of mechanotransduction in wound healing, which may lead to tangible improvements in patient wound care. The video demonstration acco.......
This work was supported by the Center for Dental, Oral, and Craniofacial Tissue and Organ Regeneration Interdisciplinary Translational Project Awards supported by the National Institute of Dental and Craniofacial Research (U24 DE026914) (G.C.G) and the Plastic Surgery Foundation Translational Research Grant (837107) (K.C.).
....Name | Company | Catalog Number | Comments |
100 mL PYREX Griffin beaker | Milipore Signma | CLS1000100 | |
Aesculap Exacta mini trimmer | Aesculap | ||
AutoClip System | Fine Surgical Instruments | 12020-00 | |
BD brand isopropyl alcohol swabs | Fisher Scientific | 13-680-63 | |
Buprenorphine SR (0.5 mg/mL) | Buprenex, Indivior Inc. | 12496-0757-1 | |
C57/BL6 females (6–8 weeks old) | The Jackson Laboratory | 000664 | |
Covidien sterile gauze | Fisher Scientific | 2187 | |
Covidien TelfaTM non-adherent pads | Fisher Scientific, Covidien | 1961 | |
Dental surgical ruler | DoWell Dental Products | S1070 | |
Depilatory cream (Nair Hair Remover Lotion) | Church&Dwight, CVS | 339823 | |
Ethanol 70% solution | Fisher Scientific | 64-17-5 | |
Excel | Microsoft Cooperation | Microsoft.com | software program |
ImageJ | ImageJ, Wayne Rasband | imagej.net | software program |
Inhalation anesthesia system | VetEquip | 922130 | |
Iris scissors 4½ in. stainless | McKesson | 43-2-104 | |
Isoflurane, USP | Dechra Veterinary Products | 17033-094-25 | |
Kaka industrial MUB-1 | Kaka Industrial | 173207 | Only necessary if there is no maker space or fabrication shop available |
Leone Rapid Palatal Expander- 13 mm | Great Lakes Dental Technologies | 125-004 | The key necessary to expand and cotnract the device will come with this product in the box |
Liquid repellent drape 75 x 90 cm with adhesive hole 6 x 9 cm | Omnia S.p.A. | 12.T4362 | |
Medequip Depot Silk Black Braided Sutr 6-0 Rx | Medequip Depot D707N, Fisher Scientific | NCO835822 | |
Needle holder 5 in. with serrated jaws | McKesson | 43-2-842 | |
Prism 9 | GraphPad Holdings, LLC | graphpad.com | software program |
Puralube ophthalmic ointment | Dechra, NDC | 17033-211-38 | |
R studio Desktop | RStudio PBC | rstudio.com | software program |
Surgical skin marker | McKesson | 19-1451_BX | |
Tegaderm, 3 M | VWR | 56222-191 | foam adhesive dressing |
Thermo-peep heating pad | K&H, Amazon | ||
Tissue forceps 4Âľ in. stainless 1 x 2 teeth | Mckesson | 43-2-775 | |
Vetbond (3 M) | Saint Paul, MN | 1469SB |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved